Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review

Chronic liver disease (CLD), manifested as hepatic injury, is a major cause of global morbidity and mortality. CLD progresses to fibrosis, cirrhosis, and—ultimately—hepatocellular carcinoma (HCC) if left untreated. The different phenotypes of CLD based on their respective clinical features and causa...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghemo, Alessio, Alekseeva, Olga P., Angelico, Francesco, Bakulin, Igor G., Bakulina, Natalia V., Bordin, Dmitry, Bueverov, Alexey O., Drapkina, Oxana M., Gillessen, Anton, Kagarmanova, Elvira M., Korochanskaya, Natalia V., Kucheryavii, U. A., Lazebnik, Leonid B., Livzan, Maria A., Maev, Igor V., Martynov, Anatolii I., Osipenko, Marina F., Sas, Evgenii I., Starodubova, Antonina, Uspensky, Yurii P., Vinnitskaya, Elena V., Yakovenko, Emilia P., Yakovlev, Alexey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Gastroenterology & Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186366/
https://www.ncbi.nlm.nih.gov/pubmed/35635048
http://dx.doi.org/10.1080/07853890.2022.2069854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186366/
https://www.ncbi.nlm.nih.gov/pubmed/35635048
http://dx.doi.org/10.1080/07853890.2022.2069854

Ejemplares similares